Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for Ocular Microfilarial Clearance in Onchocerciasis
NCT03517462Completed
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of CHILD-IVITAB in onchocerciasis, sponsored by Washington University School of Medicine. Primary endpoints: Number of participants with complete microfilaria clearance from the eye at 3 months and Number of participants with complete microfilaria clearance from the eye at 6 months. Started Aug 2018; status: completed.
02
Drugs
CHILD-IVITAB
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on NCT03517462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03517462.